Article Sidebar
Published:
Aug 31, 2007Article Details
Issue
Section
Articles
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the SA Academy of Family Practice/Primary Care. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.
Main Article Content
The management of adults and children with moderate severity asthma
Abstract
Moderate severity asthma occurs in approximately 10 to 15% of patients with chronic reversible airway obstruction and is defined by more than four daytime symptoms per week, more than four night time symptoms per month and peak expiratory flow rates of between 60 and 80% of predicted values. Currently recommended first line chronic maintenance treatment for children and adults for moderate severity asthma is the use of combination therapy of inhaled corticosteroids and long acting beta-2 agonists. Other agents such as leukotriene receptor antagonist, theophyllines and soluble TNF alpha-receptor blockers could be considered in special circumstances when adequate control is not obtained.
South African Family Practice Vol. 49 (4) 2007: pp. 28-32
